Christopher Bruno

Christoper Bruno is Partner in the Washington, DC office of McDermott, Will & Emery, where his practice focuses on intellectual property litigation matters, primarily those involving life sciences patents. Chris’s patent caseload has included complex litigation involving pharmaceutical, immunology, medical device, agritech and computing systems technology in federal district courts, the International Trade Commission (ITC), the Patent Trial and Appeal Board (PTAB), the US Court of Appeals for the Federal Circuit and the US Supreme Court. Chris was one of the first attorneys to litigate novel issues of statutory construction of the Biologics Price Competition and Innovation Act.

In the area of pharmaceuticals, Chris has experience at every stage of litigation representing both plaintiffs and defendants in small-molecule and biologics patent infringement actions related to antibiotics, overactive bladder solid oral dosage forms, gastrointestinal disease treatments, cancer-treatment drugs, sleep aid medications, topical psoriasis lotions, and fungal infection ointments in federal district court, including Arazlo®, Bryhali®, Cubicin®, Doribax®,Duobrii®, Gemzar®, Glumetza®, Hetlioz®, Jublia®, Lunesta®, Myrbetriq®, Reclast®, Remicade®, Sensipar®, Tecfidera®, Topicort®, Uceris®, Xifaxan®, and Zometa®. Chris also applies his experience with pharmaceutical companies to advance novel litigation strategies in FDA regulatory actions, including citizen’s petitions, and in counseling on patent prosecution strategy.

In the area of computing systems, Chris has experience representing defendants in technical and non-technical aspects of litigation. As one example, representing a large retail restaurant chain as the lead defendant in a large defense group, Chris was just weeks away from what would have been one of the first trials in the ever-evolving area of Section 101 invalidity. Leveraging an ability to translate complicated subject matter for judges and juries, Chris has had success handling cases with nascent technologies.

Chris also has significant experience in trademark infringement litigation representing both plaintiffs and defendants. He has counselled numerous entities, including non-profits, regarding competitors’ infringement and has worked towards alternative solutions, including favorable settlements. In one case, representing the defendant, Chris was part of a team that obtained a denial of preliminary injunction by the plaintiff that ultimately resolved the case favorably in Chris’s client’s favor.

Chris also serves as a mentor to numerous intellectual property group associates and as an assignment coordinator and mentor for IP summer associates.

Chris served as law clerk to the Hon. Todd M. Hughes for the US Court of Appeals for the Federal Circuit, and the Hon. Gail J. Standish for the US District Court for the Central District of California.